Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial-Reference-Cited by-同舟云学术

Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial

Published:2016-01-27 Issue:4 Volume:18 Page:549-556
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro Oncol

Author:

Suchorska Bogdana,Weller Michael,Tabatabai Ghazaleh,Senft Christian,Hau Peter,Sabel Michael C.,Herrlinger Ulrich,Ketter Ralf,Schlegel Uwe,Marosi Christine,Reifenberger Guido,Wick Wolfgang,Tonn Jörg C.,Wirsching Hans-Georg

Funder

University Hospital Zurich

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/18/4/549/7641072/nov326.pdf

Reference29 articles.

1. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma

2. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

3. A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

4. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

5. Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re-irradiation treatment regimens for patients with recurrent glioma – Evaluation of the optimal dose and best concurrent therapy;Radiotherapy and Oncology;2024-10

2. Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment Paradigms;International Journal of Molecular Sciences;2024-06-19

3. Tumour growth rate predicts overall survival in patients with recurrent WHO grade 4 glioma;BMC Medical Imaging;2024-05-27

4. Effect of radiochemotherapy on peripheral immune response in glioblastoma;Cancer Immunology, Immunotherapy;2024-05-16

5. Prognosis of glioblastoma patients improves significantly over time interrogating historical controls;European Journal of Cancer;2024-05